132 related articles for article (PubMed ID: 1972550)
1. Pretreatment with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline accelerates the electroshock-induced decrease in density of beta-adrenoceptors but not functional downregulation.
Pilc A; Vetulani J
Neuropharmacology; 1990 May; 29(5):469-73. PubMed ID: 1972550
[TBL] [Abstract][Full Text] [Related]
2. An in vivo procedure for the selective inactivation of rat brain cerebral cortical alpha-adrenoceptors using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Pilc A; Vetulani J; Nomura S; Enna SJ
Brain Res; 1989 Jul; 493(1):8-13. PubMed ID: 2570619
[TBL] [Abstract][Full Text] [Related]
3. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible receptor inactivator, as a tool for measurement of alpha 2-adrenoceptor occupancy in vivo.
Pilc A; Nowak G; Zak J
Eur J Pharmacol; 1992 Feb; 212(1):109-11. PubMed ID: 1348228
[TBL] [Abstract][Full Text] [Related]
4. The turnover of rat cortical alpha 1-adrenoceptors is not modified by repeated electroconvulsive treatment.
Nowak G; Zak J
J Neurochem; 1991 Jun; 56(6):2004-6. PubMed ID: 1673997
[TBL] [Abstract][Full Text] [Related]
5. Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Ribas C; Miralles A; García-Sevilla JA
Br J Pharmacol; 1993 Sep; 110(1):99-106. PubMed ID: 8106111
[TBL] [Abstract][Full Text] [Related]
6. Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Adler CH; Meller E; Goldstein M
Eur J Pharmacol; 1985 Oct; 116(1-2):175-8. PubMed ID: 2865161
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha 2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats.
Engberg G; Eriksson E
Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):472-7. PubMed ID: 1652697
[TBL] [Abstract][Full Text] [Related]
8. Chronic clorgyline induces selective down-regulation of alpha2-adrenoceptor agonist binding sites in rat brain.
Miralles A; Ribas C; Escribá PV; García-Sevilla JA
Pharmacol Toxicol; 2000 Dec; 87(6):269-75. PubMed ID: 11140825
[TBL] [Abstract][Full Text] [Related]
9. Covariation of alpha 2-adrenoceptor density and function following irreversible antagonism with EEDQ.
Durcan MJ; Morgan PF; Van Etten ML; Linnoila M
Br J Pharmacol; 1994 Jul; 112(3):855-60. PubMed ID: 7921612
[TBL] [Abstract][Full Text] [Related]
10. Agonist-induced regulation of adrenoceptor subtypes in cerebral cortical slices.
Nukina I; LaBella FS
J Neurochem; 1987 Aug; 49(2):389-92. PubMed ID: 3037026
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
Miralles A; Ribas C; Olmos G; García-Sevilla JA
J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980
[TBL] [Abstract][Full Text] [Related]
12. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
Neve KA; Molinoff PB
Mol Pharmacol; 1986 Aug; 30(2):104-11. PubMed ID: 3016496
[TBL] [Abstract][Full Text] [Related]
13. The influence of electroshock on adrenoceptor function in rat brain cerebral cortex: selectivity for the alpha-adrenoceptor site.
Pilc A; Chalecka-Franaszek E; Nalepa I; Vetulani J; Enna SJ
Eur J Pharmacol; 1988 Oct; 156(1):143-7. PubMed ID: 2850206
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic lithium treatment on the turnover of alpha2-adrenoceptors after chemical inactivation in rats.
Carbonell L; Cuffí ML; Forn J
Eur Neuropsychopharmacol; 2004 Dec; 14(6):497-502. PubMed ID: 15589389
[TBL] [Abstract][Full Text] [Related]
15. Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro.
Ruffolo RR; Messick K; Horng JS
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):317-26. PubMed ID: 6090958
[TBL] [Abstract][Full Text] [Related]
16. Effects of clenbuterol on central beta-1 and beta-2 adrenergic receptors of the rat.
Ordway GA; O'Donnell JM; Frazer A
J Pharmacol Exp Ther; 1987 Apr; 241(1):187-95. PubMed ID: 3033200
[TBL] [Abstract][Full Text] [Related]
17. Occupancy-response relationships for beta- and alpha 2-adrenergic receptors exerting opposing effects on cAMP production.
Atkinson BN; Minneman KP
Receptor; 1992; 2(3):195-206. PubMed ID: 1361869
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cyclic AMP accumulation by alpha 2-adrenoceptors in the rat cerebral cortex.
Kuno N; Kamisaki Y; Itoh T
Eur J Pharmacol; 1990 Feb; 176(3):281-7. PubMed ID: 1970302
[TBL] [Abstract][Full Text] [Related]
19. Effects of the alkylating agent EEDQ on regulatory G proteins and recovery of agonist and antagonist alpha2-adrenoceptor binding sites in rat brain.
Ribas C; Miralles A; Escribá PV; García-Sevilla JA
Eur J Pharmacol; 1998 Jun; 351(1):145-54. PubMed ID: 9698216
[TBL] [Abstract][Full Text] [Related]
20. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.
Barturen F; Garcia-Sevilla JA
Mol Pharmacol; 1992 Nov; 42(5):846-55. PubMed ID: 1359398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
